WEINAS® PD-160 series

IV COMPOUNDING ROBOTS HAS SIGNIFICANT ADVANTAGES IN ACCURACY AND CONSISTENCY,

AS WELL AS OCCUPATIONAL SAFETY AND COST SAVINGS.

MEDICATION SAFETY AND QUALITY

  • Provides continuous ISO Class 5 sterile environment controlled by a HEPA-certified air filtration system to help contain and minimize any airborne contamination.

  • Utilizes image recognition and barcode scanning to verify the order and ingredients.

  • Records the compounding procedure via multiple cameras.

  • Reduces the risk of particulate contamination by using a patented liquid transfer system.

ACCURACY

  • Performs IV compounding with full-automatic, programmable, whole process and in-process quality control for individual patient-specific or batch compounding.

  • Utilizes gravimetric methodology, robotic vision, and advanced algorithm to provide unsurpassed accuracy for sterile compounding.

  • Conducts real-time monitoring and feedback control via closed-loop system to ensure superior reproducibility.

OCCUPATIONAL SAFETY

  • Maintain continuous negative pressure inside the chamber and fully-closed environment during the entire compounding process.

  • Operators are completely isolated from the drug compounding process.

  • The waste air is 100% vented to the outside through HEPA filtration without recycled air.

  • Automatic medical waste disposal minimizes the medical staff’s exposure to cytotoxic drugs.

EFFICIENCY & COMPATIBILITY

  • Patented liquid transfer system provides superior efficiency compared to syringes-based systems, with faster, smoother operation.

  • A single operator is able to manipulate multiple robots.

  • Compatible with a wide variety of containers, such as vials, ampoules, IV bags, IV bottles, elastomeric pumps, and cassettes.

  • Supports patient-specific, batch compounding, and other compounding practices.

Weinas Onco Basic Specification

Hospitals that utilize the Weinas Onco series (Partial list)